ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2189

Impact of a Fatigue and Energy Management Program for Persons with Systemic Sclerosis (FAME-iSS): A Pilot Study

Janet Poole1, Deirdre Connolly2, Jessica Salazar3 and Kristine Carandang4, 1University of New Mexico, Albuquerque, NM, 2School of Medicine, Trinity College, Dublin, Ireland, 3University of New Mexico, Occupational Therapy Graduate Program, Albuquerque, NM, 4Young Patients' Autoimmune Research & Empowerment Alliance, San Diego, CA

Meeting: ACR Convergence 2022

Keywords: education, patient, Fatigue, Occupational therapy, Systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2022

Title: Abstracts: Cognition and Behavior in RA and Systemic Sclerosis

Session Type: Abstract Session

Session Time: 3:00PM-4:00PM

Background/Purpose: Fatigue is one of the most prevalent and disabling symptom reported by people with systemic sclerosis (SSc). No fatigue-specific programs exist for people with SSc despite the negative impact on daily life activities. Fatigue and Activity Management Education (FAME-ISS) is a six-week virtual program led by occupational therapists that was adapted for SSc. Topics covered factors related to fatigue, management of energy, pain and joint protection, stress, physical activity, and nutrition. Each session consisted of education and goal setting. The purpose of the study was to assess the impact of FAME-iSS on fatigue management and self-efficacy in persons with SSc.

Methods: Participants were recruited from the National Scleroderma Foundation newsletter and chapters. Inclusion criteria were older than 18 years of age, access to device with videoconferencing capabilities, and at least moderate fatigue determined by degree, severity, and distress (scales: 1-10). Three separate six-week programs were facilitated with 18 people with SSc. Participants completed a demographic questionnaire, and self-report measures for fatigue and self-efficacy: the Multidimensional Assessment of Fatigue (MAF), Modified Fatigue Impact Scale (m-FIS), Hospital Anxiety and Depression Scale (HADS), Self-Efficacy for Performing Energy Conservation Strategies Assessment (SEPESCA), and PROMIS Self-Efficacy for Managing Symptoms. Data collection occurred before, immediately after, and three months post-intervention. Data were analyzed using descriptive and nonparametric inferential statistics. Participants also gave qualitative feedback on the program.

Results: Two men and 16 women participated in the study. Mean age was 52.0± 11.6 years, disease duration was 13.7 ± 14.5 years, 61% were non-Hispanic white, over 70% completed a college degree and 72% were married. Significant improvements were seen in median scores for fatigue on the MAF (p=.004), self-efficacy for managing symptoms (p=.002) and the SEPESCA (p=.016) immediately post-intervention which continued to significantly improve between post-intervention and the three-month follow-up (p values = .001, .006, .035 respectively). Significant improvements were also observed for the m-FIS between baseline and the three-month follow up (p=.029). Participants reported that the format and content of FAME-iSS allowed for them to “dig deeper” into the relationship between their scleroderma, fatigue, and behaviors that were in their control. Complementing educational components led by facilitators, participants liked being able to share strategies and experiences with one another, citing that “there was a power in our group because we had a common condition.”

Conclusion: The findings suggest that FAME-iSS resulted in improvements in the impact of fatigue, self-efficacy for managing symptoms and performing energy conservation strategies in persons with established SSc. Feedback from the participants was positive and the virtual format allowed for greater accessibility and sharing of strategies amongst the participants.


Disclosures: J. Poole, None; D. Connolly, None; J. Salazar, None; K. Carandang, None.

To cite this abstract in AMA style:

Poole J, Connolly D, Salazar J, Carandang K. Impact of a Fatigue and Energy Management Program for Persons with Systemic Sclerosis (FAME-iSS): A Pilot Study [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/impact-of-a-fatigue-and-energy-management-program-for-persons-with-systemic-sclerosis-fame-iss-a-pilot-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/impact-of-a-fatigue-and-energy-management-program-for-persons-with-systemic-sclerosis-fame-iss-a-pilot-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology